BRPI0912811A2 - "vacinas de haemophilus influenzae não-tipáveis ne seus usos" - Google Patents

"vacinas de haemophilus influenzae não-tipáveis ne seus usos"

Info

Publication number
BRPI0912811A2
BRPI0912811A2 BRPI0912811A BRPI0912811A BRPI0912811A2 BR PI0912811 A2 BRPI0912811 A2 BR PI0912811A2 BR PI0912811 A BRPI0912811 A BR PI0912811A BR PI0912811 A BRPI0912811 A BR PI0912811A BR PI0912811 A2 BRPI0912811 A2 BR PI0912811A2
Authority
BR
Brazil
Prior art keywords
haemophilus influenzae
typeable haemophilus
influenzae vaccines
vaccines
typeable
Prior art date
Application number
BRPI0912811A
Other languages
English (en)
Inventor
Dunkley Margaret
Clancy Robert
Original Assignee
Hunter Immunology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hunter Immunology Ltd filed Critical Hunter Immunology Ltd
Publication of BRPI0912811A2 publication Critical patent/BRPI0912811A2/pt
Publication of BRPI0912811B1 publication Critical patent/BRPI0912811B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/102Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/095Neisseria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891Coated capsules; Multilayered drug free capsule shells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BRPI0912811-5A 2008-09-17 2009-09-17 Vacina monobacteriana BRPI0912811B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9772908P 2008-09-17 2008-09-17
US61/097,729 2008-09-17
PCT/IB2009/007303 WO2010032141A2 (en) 2008-09-17 2009-09-17 Non-typeable haemophilus influenzae vaccines and their uses

Publications (2)

Publication Number Publication Date
BRPI0912811A2 true BRPI0912811A2 (pt) 2018-06-26
BRPI0912811B1 BRPI0912811B1 (pt) 2021-08-03

Family

ID=42039960

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0912811-5A BRPI0912811B1 (pt) 2008-09-17 2009-09-17 Vacina monobacteriana

Country Status (9)

Country Link
US (2) US9943584B2 (pt)
EP (1) EP2334311B1 (pt)
JP (2) JP2012502898A (pt)
KR (4) KR101854904B1 (pt)
CN (1) CN102159225B (pt)
AU (1) AU2009294321B2 (pt)
BR (1) BRPI0912811B1 (pt)
MX (1) MX2011002052A (pt)
WO (1) WO2010032141A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009294321B2 (en) * 2008-09-17 2014-02-13 Hunter Immunology Pty Ltd Non-typeable Haemophilus influenzae vaccines and their uses
WO2013160335A2 (en) * 2012-04-26 2013-10-31 Novartis Ag Antigens and antigen combinations
US10279026B2 (en) * 2012-04-26 2019-05-07 Glaxosmithkline Biologicals Sa Antigens and antigen combinations
JP7180067B2 (ja) 2017-11-06 2022-11-30 日本電気株式会社 運転支援装置
US12029767B2 (en) * 2020-06-02 2024-07-09 Telethon Kids Institute Treating or preventing respiratory infection

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US487309A (en) * 1892-12-06 weishaupt
US4873090A (en) * 1985-03-27 1989-10-10 Broncostat Pty. Limited Non-adjuvenated vaccine
SE466259B (sv) * 1990-05-31 1992-01-20 Arne Forsgren Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
JPH08508247A (ja) * 1993-03-11 1996-09-03 セクレテック,インク. 粘膜表面への免疫原の輸送における重合的粘膜付着体
US5770213A (en) * 1994-05-05 1998-06-23 American Cyanamid Company Purified nontypable haemophilus influenzae P5 protein as a vaccine for nontypable haemophilus influenzae infection
US6245337B1 (en) * 1994-08-25 2001-06-12 Washington University Haemophilus adherence and penetration proteins
EP0952824B1 (en) 1996-06-06 2004-09-29 Bifodan A/S Enteric coating, comprising alginic acid, for an oral preparation
EP1725256A4 (en) * 2004-02-18 2008-12-31 Univ Newcastle Res Ass VACCINE FORMULATION FOR ADMINISTRATION TO THE LUNGSSCHLEIMHAUT
WO2005096823A1 (en) * 2004-04-01 2005-10-20 The Research Foundation Of State University Of New York At Buffalo Vaccine for nontypeable haemophilus influenzae infection
CA2577165C (en) * 2004-08-17 2015-01-27 Hunter Immunology Pty Limited Oral killed vaccines and method for providing same
US20080044843A1 (en) 2005-12-21 2008-02-21 Lorah Perlee Biomarkers for chronic obstructive pulmonary disease
US20080108079A1 (en) 2006-11-07 2008-05-08 Stephanie Chissoe Genes associated with copd
US20080181932A1 (en) * 2007-01-30 2008-07-31 Drugtech Corporation Compositions for oral delivery of pharmaceuticals
EP2117586B1 (en) * 2007-03-15 2018-08-08 Hunter Immunology Pty Ltd Treatment or prophylaxis of asthma
WO2008109957A1 (en) * 2007-03-15 2008-09-18 Hunter Immunology Limited Method for determining suitability of treatment for asthma or chronic airways disease
AU2009294321B2 (en) * 2008-09-17 2014-02-13 Hunter Immunology Pty Ltd Non-typeable Haemophilus influenzae vaccines and their uses

Also Published As

Publication number Publication date
MX2011002052A (es) 2011-04-07
JP2012502898A (ja) 2012-02-02
KR102257651B1 (ko) 2021-05-28
EP2334311B1 (en) 2021-03-10
US9943584B2 (en) 2018-04-17
EP2334311A2 (en) 2011-06-22
KR20200009156A (ko) 2020-01-29
CN102159225B (zh) 2013-11-13
JP2015129165A (ja) 2015-07-16
US20110206765A1 (en) 2011-08-25
WO2010032141A3 (en) 2010-05-14
AU2009294321A1 (en) 2010-03-25
KR101854904B1 (ko) 2018-06-20
EP2334311A4 (en) 2013-04-24
WO2010032141A2 (en) 2010-03-25
KR20110069102A (ko) 2011-06-22
KR20180049197A (ko) 2018-05-10
KR20180132178A (ko) 2018-12-11
CN102159225A (zh) 2011-08-17
AU2009294321B2 (en) 2014-02-13
JP6243367B2 (ja) 2017-12-06
BRPI0912811B1 (pt) 2021-08-03
US20180125963A1 (en) 2018-05-10

Similar Documents

Publication Publication Date Title
BRPI0807160A2 (pt) vacinas baseadas no direcionamento de antígeno ao dcir expresso em células apresentadoras de antígeno
IT1403365B1 (it) Metodo e macchina perfezionati per preparare caffe' espresso
BRPI0913707A2 (pt) "artigo e métodos para preparação do artigo"
EP2038459A4 (en) 3D FIBER AND ITS MANUFACTURE
BRPI0914449A2 (pt) "método de fabricação de artigo absorvente"
EP2049559A4 (en) IMPROVED VACCINES AND METHOD FOR THEIR USE
BRPI0923006A2 (pt) vacinas meningococicas incluindo receptor de hemoglobina
BRPI0914533A2 (pt) "métodos"
BRPI0914354A2 (pt) "métodos e artigos"
ZA200908001B (en) Improvements in or relating to searching techniques
EP2220058A4 (en) HETEROARYL SALTS AND METHODS OF MAKING AND USING THEM
PL2503004T3 (pl) 17 alfa-propionian korteksolonu w I postaci krystalicznej
BRPI0907217A2 (pt) Modelo de cabeça em o.
BRPI0819958A2 (pt) "artigo absorvente"
ZA201000806B (en) Immunogenic streptococcus proteins
BRPI0912811A2 (pt) "vacinas de haemophilus influenzae não-tipáveis ne seus usos"
GB0817306D0 (en) Improvements in or relating to baby care
FR2936684B1 (fr) Anorak transformable en duvet.
BRPI0908884A2 (pt) uso de bactérias haemophilus parasuis de sorotipo 5
GB0401036D0 (en) Improvements in or relating to vaccination
PL2429334T3 (pl) Klamerka do paska od smoczka
EP2348865A4 (en) BETA-HYDROXY-GAMMA-AMINOPHOSPHONATES, THEIR METHODS OF PREPARATION AND THEIR USE
GB2435995B (en) Improvements in or relating to clips
GB0614962D0 (en) Complex for use in vaccines
FI7565U1 (fi) Moniominaisuuksinen tyyny

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25F Entry of change of name and/or headquarter and transfer of application, patent and certif. of addition of invention: change of name on requirement

Owner name: HUNTER IMMUNOLOGY LIMITED. (AU)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001

B25D Requested change of name of applicant approved

Owner name: HUNTER IMMUNOLOGY PTY LIMITED (AU)

B25G Requested change of headquarter approved

Owner name: HUNTER IMMUNOLOGY PTY LIMITED (AU)

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/09/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.